COVID-19 testing in India: DCGI gives approval to commercial launch of low-cost ‘Feluda’ test
The test makes use of an indigenous, “cutting-edge” CRISPR technology COVID-19 testing: Tata CRISPR low-cost COVID-19 test’s commercial launch approved! The Drugs Controller General of India (DCGI) on Saturday approved ‘Feluda’, the Tata Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) test powered by the CSIR-IGIB, for commercial launch, Union Ministry of Science and Technology’s CSIR … Read more